Live webinar air date: April 7, 2026, 1 p.m., Eastern time
Date
CE credits
1.5
Description
Presenter disclaimer: Aaron Goldman, PhD has a working relationship with DNALabs and as such has both a financial and an intellectual interest in the program content. The purpose of this CE session is to provide a balanced view of the role of pharmacogenomics in mental health care and its application in clinical practice.
This program explores the role of genetics in mental health and well-being, including aspects of emotional regulation, stress response, and cognitive functioning and decline. The presenter explains how to use DNA testing to enhance mental health care through two innovative approaches: Foundations of Mental Health examines nutrition/lifestyle-related genetic markers to support brain function and mood regulation while Foundations of Pharmacogenomics analyzes responses to medications to optimize efficacy and reduce side effects. Additionally, the presenter will discuss how to apply these tools into your clinical practice to enhance treatment planning, increase intervention options, and add a new revenue line to your practice. Ideal for mental health professionals seeking evidence-based strategies to improve patient outcomes.
Program disclaimer: This CE session is paid for by DNALabs and does not reflect the views of APA or its editorial staff. Email CPE to learn more. DNALabs is dedicated to the new frontier of genome laboratory testing and the transformation to personalized medicine with developing affordable and cutting-edge genetic testing products.
Can’t attend this program?
You can also view it live on November 10, 2026.
Learning objectives
- Describe at least three genetic contributions to aspects of mental health and psychological well-being.
- Discuss the role of nutritional/lifestyle-related genetic markers to support brain functioning and mood regulation.
- Identify at least three ways that genetic assessments could improve your treatment planning or outcomes.
Presenters
Aaron Goldman, PhD
Goldman, chief science officer at DNALabs, oversees genetic test design, interpretation, and implementation, while supporting strategic initiatives. Previously, he directed Genomics Services at University Health Network’s Clinical Genomics Centre and co-founded Mt. Sinai Hospital’s Office of Personalized Genomics and Innovative Medicine to integrate genomic discoveries into clinical practice. He holds a PhD in molecular genetics from Yale University and completed postdoctoral studies at the University of Toronto.
